Is a 3‑day course of moxifloxacin sufficient for treating a cat‑bite abscess in a patient who cannot take penicillins, tetracyclines, or sulfonamides?

Cat-bite abscess: Is 3 days of moxifloxacin enough?

No—use moxifloxacin 400 mg daily for at least 5–7 days (often 7–10 days) with prompt incision and drainage; 3 days is insufficient and risks treatment failure and serious morbidity. 1, 2

• Rationale (mortality/morbidity/QoL prioritized):
  • Cat-bite infections are polymicrobial (Pasteurella spp., streptococci, staphylococci, anaerobes) and frequently progress without adequate duration and source control. Guidelines list moxifloxacin 400 mg daily as acceptable monotherapy for animal bites due to aerobic and anaerobic coverage, but do not support 3-day courses; typical treated infections require ≥5–7 days, often 7–10, especially with abscesses requiring drainage 1, 3.
  • FDA labeling for skin/skin-structure infections used 7-day courses; shorter 3-day regimens are not supported for abscesses, and surgical drainage was integral to success, underscoring that antibiotics alone and short durations underperform and risk relapse and complications (tenosynovitis, osteomyelitis, sepsis) 2.

Algorithm (penicillin/tetracycline/sulfonamide intolerance):

1. Immediate actions
   • Incision and drainage of abscess; send aerobic/anaerobic cultures. Delayed or inadequate drainage is the most common pitfall leading to failure and disability 3, 2.
2. Empiric antibiotic (oral)
   • Moxifloxacin 400 mg once daily monotherapy (covers Pasteurella and anaerobes) 1.
   • Duration: 5–7 days minimum if rapid clinical response after drainage; extend to 7–10 days if hand involvement, delayed source control, systemic signs, or slow response. Do not stop at 3 days 1, 2.
3. Escalate/adjust if:
   • Concern for MRSA: add doxycycline or TMP‑SMX per guidelines—however, patient cannot take tetracyclines or sulfonamides; in this constraint, rely on drainage and consider IV options (e.g., vancomycin) if MRSA is suspected clinically or by culture 1.
   • Severe infection, systemic toxicity, or deep-space/tenosynovitis: hospitalize; consider IV ampicillin-sulbactam alternatives (e.g., carbapenem) if tolerated; if beta‑lactam allergy prevents these, keep moxifloxacin and add MRSA coverage as above; urgent surgical evaluation is critical 1, 3.
4. Safety and pitfalls with moxifloxacin
   • Check QT risk, drug interactions with QT‑prolonging agents, and avoid multivalent cations around dosing; monitor for hepatotoxicity and C. difficile; counsel to complete the full course—premature discontinuation increases failure and resistance 2.

Key caveats to avoid failure

• Do not use clindamycin alone (misses Pasteurella) 1.
• Do not rely on prophylactic durations (3–5 days) for established abscesses; those apply to fresh, noninfected high‑risk wounds, not to abscess treatment 3.
• Always ensure tetanus status and evaluate rabies risk separately from antibiotic therapy 4.